Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Botet

Showing results (111-120 of 1,070) with videos related to

Pageof 107
Sort By:
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|February 10, 2020
Lipid-lowering treatment in secondary prevention of ischaemic cerebrovascular diseaseElisenda Climent, David Benaiges, Juan Pedro-Botet
The Journal of Biological Chemistry|September 5, 1992
Cyclic AMP and calcium regulate at a transcriptional level the expression of the CD7 leukocyte differentiation antigenM Rincón, A Tugores, M López-Botet
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|January 18, 2021
Atherogenic dyslipemia: the other pandemic, associated with diabesityJesús Millán Núñez-Cortés, Juan Pedro-Botet
Journal of the International Federation of Clinical Chemistry|June 7, 1992
A review of methodology for estrogen and progesterone receptor protein analysisC J Menendez-Botet, M K Schwartz
Scandinavian Journal of Immunology|January 1, 1983
Natural killer-like cytotoxicity of human T-cell clones against various target cellsM López-Botet, A Moretta, L Moretta
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|November 28, 2016
Juan Pedro-Botet, Jesús Millán Núñez-Cortés
Immunology Today|May 1, 1996
NK-cell receptors and recognition of MHC class I moleculesM López-Botet, L Moretta, J Strominger
Medicina Clinica|December 15, 2010
[Emerging risk factors related to residual risk]Jesús Millán, Juan Pedro-Botet, Xavier Pintó, et al.
Medicina Clinica|February 5, 2022
Bariatric surgery and non-alcoholic fatty liver diseaseHelena Julià, David Benaiges, Juan Pedro-Botet
Current Topics in Microbiology and Immunology|August 24, 1999
A novel family of inhibitory receptors for HLA class I molecules that modulate function of lymphoid and myeloid cellsM Colonna, F Navarro, M López-Botet
Pageof 107

Showing results (111-120 of 1,070) with videos related to

Sort By:
Pageof 107
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|February 10, 2020
Lipid-lowering treatment in secondary prevention of ischaemic cerebrovascular diseaseElisenda Climent, David Benaiges, Juan Pedro-Botet
The Journal of Biological Chemistry|September 5, 1992
Cyclic AMP and calcium regulate at a transcriptional level the expression of the CD7 leukocyte differentiation antigenM Rincón, A Tugores, M López-Botet
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|January 18, 2021
Atherogenic dyslipemia: the other pandemic, associated with diabesityJesús Millán Núñez-Cortés, Juan Pedro-Botet
Journal of the International Federation of Clinical Chemistry|June 7, 1992
A review of methodology for estrogen and progesterone receptor protein analysisC J Menendez-Botet, M K Schwartz
Scandinavian Journal of Immunology|January 1, 1983
Natural killer-like cytotoxicity of human T-cell clones against various target cellsM López-Botet, A Moretta, L Moretta
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|November 28, 2016
Juan Pedro-Botet, Jesús Millán Núñez-Cortés
Immunology Today|May 1, 1996
NK-cell receptors and recognition of MHC class I moleculesM López-Botet, L Moretta, J Strominger
Medicina Clinica|December 15, 2010
[Emerging risk factors related to residual risk]Jesús Millán, Juan Pedro-Botet, Xavier Pintó, et al.
Medicina Clinica|February 5, 2022
Bariatric surgery and non-alcoholic fatty liver diseaseHelena Julià, David Benaiges, Juan Pedro-Botet
Current Topics in Microbiology and Immunology|August 24, 1999
A novel family of inhibitory receptors for HLA class I molecules that modulate function of lymphoid and myeloid cellsM Colonna, F Navarro, M López-Botet
Pageof 107